Inner Mongolia Furui Med Sci (300049) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.06 Million ≈ $20.35 Million USD) by net assets (CN¥2.79 Billion ≈ $407.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inner Mongolia Furui Med Sci - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Inner Mongolia Furui Med Sci's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Inner Mongolia Furui Med Sci total liabilities for a breakdown of total debt and financial obligations.
Inner Mongolia Furui Med Sci Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Coty Inc
NYSE:COTY
|
0.147x |
|
Shenzhen Topband Co Ltd
SHE:002139
|
0.029x |
|
OPT Machine Vision Tech Co. Ltd. A
SHG:688686
|
0.005x |
|
Guobang Pharma Ltd
SHG:605507
|
0.038x |
|
WHA Corporation Public Company Limited
BK:WHA-R
|
0.001x |
|
Nuvoton Technology Corp
TW:4919
|
0.002x |
|
NCC AB (publ)
ST:NCC-B
|
-0.008x |
|
NOS S.G.P.S. S.A.
LS:NOS
|
0.145x |
Annual Cash Flow Conversion Efficiency for Inner Mongolia Furui Med Sci (2006–2025)
The table below shows the annual cash flow conversion efficiency of Inner Mongolia Furui Med Sci from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Inner Mongolia Furui Med Sci.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.79 Billion ≈ $407.78 Million |
CN¥354.15 Million ≈ $51.82 Million |
0.127x | +22.14% |
| 2024-12-31 | CN¥2.13 Billion ≈ $311.38 Million |
CN¥221.41 Million ≈ $32.40 Million |
0.104x | -36.95% |
| 2023-12-31 | CN¥1.85 Billion ≈ $270.33 Million |
CN¥304.89 Million ≈ $44.61 Million |
0.165x | +59.05% |
| 2022-12-31 | CN¥1.83 Billion ≈ $267.18 Million |
CN¥189.46 Million ≈ $27.72 Million |
0.104x | -15.81% |
| 2021-12-31 | CN¥1.81 Billion ≈ $264.23 Million |
CN¥222.55 Million ≈ $32.57 Million |
0.123x | -0.52% |
| 2020-12-31 | CN¥1.62 Billion ≈ $236.40 Million |
CN¥200.15 Million ≈ $29.29 Million |
0.124x | -24.98% |
| 2019-12-31 | CN¥1.55 Billion ≈ $227.04 Million |
CN¥256.23 Million ≈ $37.49 Million |
0.165x | +219.10% |
| 2018-12-31 | CN¥1.51 Billion ≈ $221.53 Million |
CN¥78.35 Million ≈ $11.46 Million |
0.052x | -24.72% |
| 2017-12-31 | CN¥1.92 Billion ≈ $280.39 Million |
CN¥131.72 Million ≈ $19.27 Million |
0.069x | -15.69% |
| 2016-12-31 | CN¥1.83 Billion ≈ $267.13 Million |
CN¥148.84 Million ≈ $21.78 Million |
0.082x | -14.91% |
| 2015-12-31 | CN¥1.65 Billion ≈ $241.53 Million |
CN¥158.16 Million ≈ $23.14 Million |
0.096x | +72.35% |
| 2014-12-31 | CN¥915.10 Million ≈ $133.91 Million |
CN¥50.88 Million ≈ $7.44 Million |
0.056x | +47.66% |
| 2013-12-31 | CN¥748.53 Million ≈ $109.53 Million |
CN¥28.18 Million ≈ $4.12 Million |
0.038x | -67.84% |
| 2012-12-31 | CN¥733.64 Million ≈ $107.35 Million |
CN¥85.88 Million ≈ $12.57 Million |
0.117x | +8.65% |
| 2011-12-31 | CN¥703.08 Million ≈ $102.88 Million |
CN¥75.75 Million ≈ $11.08 Million |
0.108x | +50.54% |
| 2010-12-31 | CN¥687.42 Million ≈ $100.59 Million |
CN¥49.20 Million ≈ $7.20 Million |
0.072x | +637.68% |
| 2009-12-31 | CN¥157.46 Million ≈ $23.04 Million |
CN¥-2.10 Million ≈ $-306.69K |
-0.013x | -105.09% |
| 2008-12-31 | CN¥139.52 Million ≈ $20.42 Million |
CN¥36.47 Million ≈ $5.34 Million |
0.261x | +87.15% |
| 2007-12-31 | CN¥127.76 Million ≈ $18.70 Million |
CN¥17.85 Million ≈ $2.61 Million |
0.140x | -64.88% |
| 2006-12-31 | CN¥124.50 Million ≈ $18.22 Million |
CN¥49.52 Million ≈ $7.25 Million |
0.398x | -- |
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more